Recordati

News

Just Don't in capital white letters on side of building

Resistance grows to Recordati's private equity takeover

The offer for Recordati by private equity firms CVC and GBL undervalues the company and is unfair to minority shareholders, claims activist investor.

News

Ionis' Tryngolza claims critical label expansion in US

Ionis' Tryngolza has been approved for severe hypertriglyceridaemia, opening the door to what the company thinks could be a $3bn market opportunity.

News

GBL joins CVC in €10.7bn takeover bid for Recordati

A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.

News

Recordati gets €10.9bn takeover bid from private equity firm

Recordati has received a takeover offer from private equity group CVC that, if completed, would delist it from the Italian stock exchange.

News

Autolus closes on EU okay for leukaemia cell therapy

The CHMP backed approval of Autolus' leukaemia CAR-T Aucatzyl, as well as drugs from GSK, Roche, SpringWorks, and others, at its May meeting.

News

White House says 48 drugs are heading for Medicare rebates

The Biden administration has generated a list of 48 drugs whose prices were raised faster than inflation in the last quarter of this year and may be subject to the mandato

Resistance grows to Recordati's private equity takeover

Ionis' Tryngolza claims critical label expansion in US

GBL joins CVC in €10.7bn takeover bid for Recordati

Recordati gets €10.9bn takeover bid from private equity firm

Autolus closes on EU okay for leukaemia cell therapy

White House says 48 drugs are heading for Medicare rebates

CHMP backs Novo's haemophilia A drug Frehemgo

Discover a new era of healthcare panel engagement: Grounded ...

Recordati

Editor's Picks